Grant to Gilead Sample Clauses

Grant to Gilead. For any Optioned Program, the licenses and other rights granted to Gilead under ARTICLE V, ARTICLE VI, ARTICLE VII, ARTICLE VIII, and Section 13.3 shall be effective as of each Option Exercise Closing for such Optioned Program in the Gilead Territory.
Sample 1
AutoNDA by SimpleDocs
Grant to Gilead. For any Optioned Program other than the PD-1 Program, the licenses and other rights granted to Gilead under this Section 8.4 shall be effective as of each Option Exercise Closing for such Optioned Program in the countries to which such Option Exercise Closing relates. (a) For each Optioned Program, subject to Section 8.6, Arcus, on behalf of itself and its Affiliates, hereby grants to Gilead an exclusive (including as to Arcus), royalty-bearing (solely with respect to the Gilead Royalty Territory pursuant to Section 9.5), sublicensable (solely in accordance with Section 8.7(a)(i)) license under the Arcus IP and Arcus’ interest in any Joint Collaboration IP, in each case, to Exploit any Optioned Molecules or Optioned Products with respect to such Optioned Program in the Field in the Gilead Territory. Such exclusive license shall be subject to (i) the retained rights of Arcus under Section 8.6 and (ii) if applicable, any rights granted to Arcus under any Co-Promotion Agreement. (b) For each Optioned Program, subject to Section 8.6, Arcus, on behalf of itself and its Affiliates, hereby grants to Gilead an exclusive (including as to Arcus), royalty-bearing (solely with respect to the Gilead Royalty Territory pursuant to Section 9.5), sublicensable (solely in accordance with Section 8.7(a)(i)) right of reference under (or right of access to, if such right of reference is unavailable or insufficient) any Regulatory Materials or Regulatory Approvals Controlled by Arcus with respect to any Optioned Molecules or Optioned Products with respect to such Optioned Program, in each case, to Exploit such Optioned Molecules or Optioned Products in the Field in the Gilead Territory. Such exclusive license shall be subject to (i) the retained rights of Arcus under Section 8.6 and (ii) any rights granted to Arcus under any Co-Promotion Agreement. (c) For each Optioned Program, subject to Section 8.6, Arcus, on behalf of itself and its Affiliates, hereby grants to Gilead a non-exclusive, royalty-bearing (solely with respect to the Gilead Royalty Territory pursuant to Section 9.5), sublicensable (solely in accordance with Section 8.7(a)(i)) right of reference under (or right of access to, if such right of reference is unavailable or insufficient) any Regulatory Materials including safety data Controlled by Arcus with respect to any Arcus Molecules or Excluded Arcus Molecules included in an Arcus Combination or an Excluded Combination, as applicable, to the extent necessary for ...
Sample 1

Related to Grant to Gilead

  • Option Grant You have been granted a NON-STATUTORY STOCK OPTION (referred to in this Agreement as your "Option"). Your Option is NOT intended to qualify as an "incentive stock option" under Section 422 of the Internal Revenue Code of 1986, as amended.

  • NOTICE OF STOCK OPTION GRANT Name: Address:

  • Date of Grant The date that the Option is granted (the “Date of Grant”) is set forth above.

  • Stock Option Grant Subject to the provisions set forth herein and the terms and conditions of the Plan, and in consideration of the agreements of the Participant herein provided, the Company hereby grants to the Participant an Option to purchase from the Company the number of shares of Common Stock, at the exercise price per share, and on the schedule, set forth above.

  • Award Agreement Each Option shall be evidenced by an Award Agreement that shall specify the Exercise Price, the expiration date of the Option, the number of Shares to which the Option pertains, any conditions to exercise of the Option, and such other terms and conditions as the Committee, in its discretion, shall determine. The Award Agreement shall specify whether the Option is intended to be an Incentive Stock Option or a Non-qualified Stock Option.

  • Option Agreement Each Option granted pursuant to this Section 9 shall be evidenced by a written stock option agreement, which shall be executed by the Non-employee Director and the Company.

  • Stock Option Plan The Executive shall be eligible to participate in the Company's Stock Option Plan in accordance with the terms and conditions thereof.

  • Grant of Warrant Subject to the terms, restriction, limitations and conditions stated herein, the Corporation hereby grants to the Warrant Holder the right (the "Warrant") to purchase all or any part of an aggregate of _______________ shares of the Common Stock, subject to adjustment in accordance with Section 7 hereof.

  • Option Plan This Option is subject to certain additional terms and ----------- conditions set forth in the Plan pursuant to which this Option has been issued. Optionee acknowledges receipt of a copy of the Plan on file with the Secretary of the Company and, by acceptance hereof, agrees to and accepts this Option subject to the terms of the Plan. Except as otherwise defined herein, defined terms used in this Agreement shall have the meaning ascribed thereto in the Plan.

  • Agreement to Purchase The Mortgage Loan Seller agrees to sell, assign, transfer, set over and otherwise convey to the Purchaser, without recourse, representation or warranty, other than as set forth herein, and the Purchaser agrees to purchase from the Mortgage Loan Seller, subject to the terms and conditions set forth herein, the Mortgage Loans. The purchase and sale of the Mortgage Loans shall take place on August 22, 2017 or such other date as shall be mutually acceptable to the parties hereto (the “Closing Date”). As of the Cut-off Date, the Mortgage Loans will have an aggregate principal balance, after application of all payments of principal due on the Mortgage Loans, if any, on or before such date, whether or not received, of $301,354,734, subject to a variance of plus or minus 5%. The purchase price for the Mortgage Loans shall be an amount set forth on the cross receipt between the Mortgage Loan Seller and the Purchaser dated the Closing Date (which price reflects no deduction for any transaction expenses for which the Mortgage Loan Seller is responsible). The Purchaser shall pay such purchase price to the Mortgage Loan Seller on the Closing Date by wire transfer in immediately available funds or by such other method as shall be mutually acceptable to the parties hereto.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!